jRCT2031220392已完成不适用
SJP-0132 Phase 3 -Multicenter, Open-label, Long-term Study in Patients with Dry Eye Disease-
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 150
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized Controlled Trial
- 干预模型
- Single Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 18age old over 至 No limit（—）
- 性别
- All
入选标准
- •Aged over 18 years at the time of the informed consent (any gender)
- •Live in Japan
- •Have continuous subjective symptoms of dry eye disease
- •Tear film break-up time of <= 5 seconds
- •Meet the other protocol-specified inclusion criteria may apply
排除标准
- •Unable to discontinue wearing contact lens during the study
- •Have a history of, or scheduled corneal transplantation during the study
- •Have a history of, or scheduled permanent punctal occlusion during the study
- •Have used or anticipates use of a punctal plug during the study - Have a history of, or scheduled ocular surface surgery during the study
- •Have ophthalmic disease other than dry eye disease - Have disease that affects subjective symptoms of dry eye - Have known history of hypersensitivity or serious adverse reaction to any of the study drug ingredients - Unable to discontinue any ophthalmic medicines including OTC, except test drug for ophthalmic examination during the study - Female participant who is pregnant, potentially pregnant, lactating or intents to become pregnant. And unable to obtain a consent to practice adequate contraception during the study - Male participant who does not agree to practice adequate contraception and not to donate sperm during the study
- •Have judged that it is inappropriate to participate in this study by investigator
- •Meet the other protocol-specified exclusion criteria
结局指标
主要结局
-
Safety
次要结局
未报告次要终点
研究者
相似试验
未知
3 期
ong-term Study of DSP-8153 in patients with essential hypertensioHypertensionJPRN-jRCT2080221238Dainippon Sumitomo Pharma Co., Ltd.
未知
Unknown
A long term study of SPP100 in patients with essential hypertensioHypertensionJPRN-jRCT2080220180ovartis Pharma K.K.300
未知
2 期
Phase II Study of S-555739 in Patients with Japanese Cedar Pollinosis in an Environmental Challenge ChamberSeasonal allergic rhinitisJPRN-jRCT2080221936SHIONOGI & CO., LTD.
已完成
1 期
EDO-S101 Phase I study for Japanese patients with relapsed/refractory hematological malignancyRelapsed/refractory Hodgkin's lymphoma, Non-Hodgkin's lymphoma, Multiple myelomaJPRN-jRCT2080224049MUNDIPHARMA K.K.15
进行中（未招募）
1 期
uovi end-points clinici in pazienti con sindrome di Sjögren primaria (pSS): uno studio interventistico basato sulla stratificazione dei pazienti.Primary Sjögren's syndrome (pSS)MedDRA version: 21.0Level: PTClassification code 10040767Term: Sjogren's syndromeSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2019-002470-32-ITASSITANCE PUBLIQUE DES HOPITAUX DE PARIS300